AbCellera Biologics Inc.

AbCellera Biologics Inc. is a biotechnology company based in Vancouver, Canada, focused on discovering and developing therapeutic antibodies. The company operates a technology-driven antibody discovery platform that integrates biology, computation, and engineering to identify drug candidates from natural immune responses for a wide range of diseases. AbCellera’s platform searches, decodes, and analyzes immune systems at scale, aiming to generate high-quality antibody leads that can be advanced into clinical development by AbCellera or its partners. It collaborates with pharmaceutical and biotechnology companies to create antibody-based medicines across multiple indications and modalities, including complex and hard-to-drug targets. Founded in 2012 and headquartered in Vancouver, British Columbia, AbCellera Biologics Inc. plays a specialized role in the biopharmaceutical ecosystem as an innovation partner, providing discovery capabilities that support the development of new antibody therapeutics for global healthcare markets.

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Carl L.G. Hansen Ph.D.

Employees

562

Headquarters

Vancouver, BC, Canada

Website

www.abcellera.com